What Is Cyanoacrylate?
Cyanoacrylate is a family of fast-acting adhesive compounds with the general formula CH₂=C(CN)-COOR. First synthesized in the 1940s, these materials are widely known in consumer form as "super glue." Medical-grade cyanoacrylates are specifically formulated and purified for biocompatibility, with longer alkyl chain lengths (n-butyl or n-octyl) that reduce tissue toxicity compared to shorter-chain variants.
The Polymerization Reaction
Cyanoacrylate undergoes anionic polymerization when it contacts weak bases — including water and blood. In the vein lumen, blood acts as the initiator: moisture on the vein wall triggers rapid polymerization of the liquid monomer into a solid polymer chain. This reaction occurs within seconds, creating immediate mechanical adhesion to the vein wall.
The reaction is exothermic but generates minimal heat (2–4°C temperature rise), far below the 50–70°C required for thermal vein wall damage — confirming that VenaBlock® is truly non-thermal in mechanism.
Medical-Grade Formulation
The cyanoacrylate in VenaBlock® is specifically formulated for intravascular use with:
- Optimized viscosity for controlled catheter delivery
- Radiopacifier for fluoroscopic visibility (optional guidance)
- Biocompatibility testing per ISO 10993 standards
- Sterilization for single-use intravascular application
Long-Term Behavior in the Vein
After injection, the polymerized cyanoacrylate provokes a foreign body granulomatous reaction that reinforces mechanical closure with a fibrotic seal. Over 12–24 months, the treated vein undergoes progressive fibrosis and absorption into surrounding tissue. Ultrasound imaging typically shows a hyperechoic cord at the treatment site, gradually becoming less visible over years.
Safety: What Happens to the Material?
Unlike fully absorbable implants, cyanoacrylate polymers remain at the treatment site for an extended period (months to years) before being gradually degraded and absorbed by macrophages. This extended dwell time is associated with sustained vein closure but also means that the foreign body reaction can occasionally produce palpable nodularity along the treated vein course — a benign, self-limiting phenomenon.
Allergic Reactions: Risk and Reality
Hypersensitivity to cyanoacrylate is a recognized but rare contraindication. Patients with known sensitivity to cyanoacrylate-based products (including some wound closure strips and nail adhesives) should be screened before treatment. The overall incidence of clinically significant allergic reactions in published VenaBlock® and VenaSeal™ series is below 1%.